Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» breast cancer
breast cancer
Bayer's drug that turns a cancer-protective pathway toxic eradicates breast tumors in mice
Fierce Biotech
Wed, 07/21/21 - 08:44 pm
Bayer
breast cancer
Systems Oncology
ErSO
Polyphor sharpens ax on staff, shutters failed breast cancer test
Fierce Biotech
Fri, 07/16/21 - 10:43 am
Polyphor
breast cancer
clinical trials
layoffs
balixafortide
FDA 'may require' post-marketing studies to analyze long-term effects of breast cancer drugs
RAPS.org
Mon, 06/21/21 - 10:13 pm
FDA
post-marketing studies
breast cancer
Hoping to challenge blockbuster breast cancer franchises, a small Dutch biotech says its ADC passed a PhIII test
Endpoints
Tue, 06/8/21 - 11:21 am
clinical trials
antibody-drug conjugate
breast cancer
Byondis
AstraZeneca Redefining Cancer Care in Breast Cancer, Leukemia at ASCO
BioSpace
Mon, 06/7/21 - 08:41 pm
AstraZeneca
ASCO 2021
breast cancer
CLL
Lynparza
Calquence
#ASCO21: Gilead's Trodelvy reads out new subgroup data showing benefit in earlier-line TNBC patients
Endpoints
Fri, 06/4/21 - 11:00 am
Gilead Sciences
Trodelvy
breast cancer
triple negative breast cancer
ASCO 2021
An AstraZeneca, Merck drug slows the return of genetic breast cancer. Will testing speed up?
BioPharma Dive
Thu, 06/3/21 - 11:11 pm
ASCO 2021
AstraZeneca
Merck
breast cancer
genetic breast cancer
Lynparza
Sanofi ASCO Preview: Addressing Unmet Needs in Breast Cancer
BioSpace
Thu, 06/3/21 - 11:08 pm
Sanofi
breast cancer
clinical trials
ASCO 2021
#ASCO21: Novartis keeps building out survival data for Kisqali, hoping to keep the pressure on Pfizer's Ibrance
Endpoints
Thu, 06/3/21 - 12:09 am
ASCO 2021
Novartis
Kisqali
breast cancer
ASCO: Sanofi says early amcenestrant data could see it be 'endocrine backbone therapy' in breast cancer
Fierce Biotech
Wed, 05/19/21 - 11:24 pm
ASCO 2021
Sanofi
breast cancer
Amcenestrant
Merck, with new breast cancer data, aims to rebound from FDA rejection
BioPharma Dive
Thu, 05/13/21 - 12:00 pm
Merck
Keytruda
breast cancer
clinical trials
FDA
triple negative breast cancer
Validation for a drug class, and for Sanofi
EP Vantage
Wed, 05/12/21 - 10:44 am
Sanofi
Serds
breast cancer
Amcenestrant
Radius Health
Elacestrant
Roche
Giredestrant
AstraZeneca
Camizestrant
A Breast Cancer Surgery Technology So Easy a 3-Year-Old Can Use It
Medical Devices and Diagnostics Industry
Sun, 05/2/21 - 10:08 pm
devices
breast cancer
breast cancer surgery
Molli Surgical
FDA panel questions Roche’s Tecentriq-Abraxane combo in breast cancer, but votes to keep approval in place for now
Fierce Pharma
Tue, 04/27/21 - 11:37 pm
Roche
Tecentriq
Abraxane
breast cancer
FDA
accelerated approvals
Celcuity and Pfizer Enter Agreement for Breast Cancer Drug Following Positive Data
BioSpace
Sun, 04/11/21 - 11:27 pm
Celcuity
Pfizer
gedatolisib
breast cancer
Pfizer's Ibrance, under threat from Novartis and Lilly, leans on real-world data in breast cancer
Fierce Pharma
Mon, 03/29/21 - 10:37 am
Pfizer
breast cancer
Ibrance
RWE
RWD
Big pharma’s key catalysts in the second quarter
EP Vantage
Wed, 03/24/21 - 10:04 am
Biogen
Alzheimer's disease
aducanumab
Sanofi
breast cancer
FDA
Look for Eli Lilly's Verzenio to hit $4.6B, thanks to early breast cancer win: analyst
Fierce Pharma
Tue, 03/2/21 - 12:12 pm
Eli Lilly
Verzenio
breast cancer
early breast cancer
Moving up the lines, AstraZeneca stakes another PhIII win for Lynparza as adjuvant breast cancer therapy
Endpoints
Wed, 02/17/21 - 11:21 am
AstraZeneca
Merck
Lynparza
clinical trials
BRCA-mutant breast cancer
breast cancer
AstraZeneca drops breast, prostate cancer programs in Q4 pipeline cull
Fierce Biotech
Thu, 02/11/21 - 10:34 am
AstraZeneca
oncology
AZD9496
breast cancer
imaradenant
prostate cancer
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »